AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. LTT Bio-Pharma Co., Ltd.
  3. Financials
  4. Gross profit

LTT Bio-Pharma Co., Ltd.【JP:E00982】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndGross profit (Million JPY)YoY (%)
Mar 31, 202536-23.76%
Mar 31, 202448+213.69%
Mar 31, 202315+201.91%
Mar 31, 20225-55.40%
Mar 31, 202111-26.23%
Mar 31, 202015-43.98%
Mar 31, 201927-25.82%
Mar 31, 201837+7.49%
Mar 31, 201734-37.51%
Mar 31, 201655+1.00%
Mar 31, 201554

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)